Monday, January 23, 2017

BRIEF-Ocular Therapeutix(tm) resubmits NDA for Dextenza(tm)

* Ocular Therapeutix(tm) resubmits NDA for Dextenza(tm) for

the treatment of ocular pain occurring after ophthalmic surgery

Read more

No comments:

Post a Comment